https://orcid.org/0000-0001-8643-6873
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Joseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou, Thomas P Hull, Shawn A Lewis, David G Miller, Michael A Novak, Scott D Pendergast, Hang Pham, Sean M Platt, Llewelyn J Rao, Jerome P Schartman, Lawrence J Singerman, Richard Donkor, Margaret Fink, Ryan Zubricky & Helene Karcher. (2023) One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents. Clinical Ophthalmology 17, pages 3601-3611.
Read now
Read now
Audrey Giocanti-Aurégan, Alfredo García-Layana, Tunde Peto, Brittany Gentile, Gloria C Chi, Mirela Mirt, Charlotte E Kosmas, Jeremy Lambert, Sally Lanar, Hannah B Lewis & Nancy M Holekamp. (2022) Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study. Patient Preference and Adherence 16, pages 587-604.
Read now
Read now
Articles from other publishers (8)
Murat Seçkin Ayhan, Hanna Faber, Laura Kühlewein, Werner Inhoffen, Gulnar Aliyeva, Focke Ziemssen & Philipp Berens. (2023) Multitask Learning for Activity Detection in Neovascular Age-Related Macular Degeneration. Translational Vision Science & Technology 12:4, pages 12.
Crossref
Crossref
Amy Basilious, Bobbi Smuck, Julie Duncan, Monali S. Malvankar-Mehta, Verena R. Juncal, Phil Hooper & Tom G. Sheidow. (2023) Patterns of anti-vascular endothelial growth factor discontinuation in neovascular age-related macular degeneration. Canadian Journal of Ophthalmology.
Crossref
Crossref
Joseph M. Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou, Thomas P. Hull, Shawn A. Lewis, David G. Miller, Michael A. Novak, Scott D. Pendergast, Hang Pham, Sean M. Platt, Llewelyn J. Rao, Jerome P. Schartman, Lawrence J. Singerman, Richard Donkor, Margaret Fink, Jasmyne McCoy & Helene Karcher. (2023) Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration. International Journal of Retina and Vitreous 9:1.
Crossref
Crossref
Lei lei Yang, Feng Zhou, Qi Xu, Ting Ye & Hong Xiong. (2022) Clinical Effect of Tongmai Fuming Decoction on Neovascular Ophthalmopathy. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-6.
Crossref
Crossref
Prem N. Patel, Parth A. Patel, Matthew R. Land, Ibrahim Bakerkhatib-Taha, Harris Ahmed & Veeral Sheth. (2022) Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration. Biomedicines 10:8, pages 1884.
Crossref
Crossref
Roee Arnon, Joseph Pikkel, Tal Yahalomi, Nir Stanescu, Keren Wood, Ari Leshno, Asaf Achiron & Assaf Hilely. (2022) The negative impact of COVID-19 pandemic on age-related macular degeneration patients treated with intravitreal bevacizumab injections. International Ophthalmology 42:11, pages 3387-3395.
Crossref
Crossref
Vivian Paraskevi Douglas, Konstantinos A. A. Douglas, Demetrios G. Vavvas, Joan W. Miller & John B. Miller. (2022) Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown. Journal of Clinical Medicine 11:8, pages 2097.
Crossref
Crossref
Juan Manuel Martinez-Alejo, Leopoldo Martin Baiza-Duran & Juan de Dios Quintana-Hau. (2022) Novel therapies for proliferative retinopathies. Therapeutic Advances in Chronic Disease 13, pages 204062232211403.
Crossref
Crossref